Clinical Trial Update: Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating mealtime versus post-meal dosing of URLi in the Medtronic 780G Hybrid Closed Loop System for Type 1 diabetes; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• URLi

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Type 1 Diabetes (T1D) | Phase 4 | Status: NOT_YET_RECRUITING